10-K: Blade Air Mobility, Inc. Reports Full Year 2023 Results, Cites Growth in Medical and Passenger Segments

Blade Air Mobility, Inc. reports a 54% increase in revenue for 2023, driven by growth in both its Medical and Passenger segments, while also highlighting ongoing challenges in achieving profitability.

Summary

• Blade Air Mobility, Inc. reported a 54% increase in revenue for the year ended December 31, 2023, reaching $225.2 million, compared to $146.1 million in 2022.
• The Medical segment saw a 76% revenue increase, reaching $126.6 million, driven by higher activity from existing clients, new hospital clients, and increased revenue per flight hour.
• The Passenger segment experienced a 33% revenue increase, totaling $98.6 million, with Short Distance revenue up 57% and Jet and Other revenue down 5%.
• The company's net loss for 2023 was $56.1 million, compared to a net loss of $27.3 million in 2022.
• Flight costs were 81% of revenue in 2023, down from 85% in 2022, due to increased use of dedicated aircraft, higher passenger load factors, and reduced jet charter costs.
• General and administrative expenses increased by 52% to $95.2 million, including a $20.8 million impairment in Blade Europe's intangible assets.
• The company's total liquidity as of December 31, 2023, was $166.1 million, consisting of cash and cash equivalents of $27.9 million and short-term investments of $138.3 million.

Sentiment

Score: 4

Explanation: The document presents a mixed picture with strong revenue growth offset by increased losses and operational challenges. The company's future success is highly dependent on the development and adoption of EVA, which is still uncertain. The material weaknesses in internal controls also raise concerns.

Positives

• The company experienced significant revenue growth in both the Medical and Passenger segments.
• Cost of revenue as a percentage of revenue decreased, indicating improved operational efficiency.
• The company's asset-light business model continues to be scalable and flexible.
• Blade's proprietary technology stack is designed to manage fliers and organ transports across numerous simultaneous flights.
• The company has a strong liquidity position with $166.1 million in total liquid funds.

Negatives

• The company's net loss increased significantly in 2023 compared to 2022.
• General and administrative expenses increased substantially, including a $20.8 million impairment in Blade Europe's intangible assets.
• The Jet and Other product line saw a decrease in revenue due to the discontinuation of the seasonal by-the-seat jet service between New York and South Florida.
• The company identified material weaknesses in its internal control over financial reporting.

Risks

• The company has incurred significant losses since inception and expects to incur losses in the future.
• The markets for the company's Passenger offerings are still in relatively early stages of growth.
• The company's success is highly dependent on its ability to effectively market and sell air transportation.
• The EVA industry may not continue to develop, and EVA may not be adopted by the market or third-party aircraft operators.
• The company relies on third-party operators to provide and operate aircraft, which exposes it to operational risks.
• The company is subject to a wide variety of extensive and evolving laws and regulations.
• The company has identified material weaknesses in its internal control over financial reporting.
• The price of the company's securities may change significantly, and investors could lose all or part of their investment.

Future Outlook

The company intends to leverage the expected lower operating costs of EVA to reduce consumer prices and develop new vertiports. The company anticipates that it has sufficient funds to meet its current operational needs for at least the next 12 months.

Management Comments

• The company's asset-light model is designed to facilitate a seamless transition to EVA.
• The company believes its technology stack will enable it to scale its business.
• The company intends to leverage the expected lower operating costs of EVA to reduce the consumers price for our flights.

Industry Context

The urban air mobility industry is still developing and evolving, and the company expects it to be highly competitive. The company is also competing with traditional transportation methods and other air transportation providers.

Comparison to Industry Standards

• The company competes with Part 135 operators and brokers of helicopters, seaplanes, and jets, many of whom offer only full aircraft charter.
• Some multimodal transportation providers and commercial airlines have expressed interest in air mobility, such as Uber Technologies, Inc. which has a significant investment in a company that is developing EVA aircraft.
• The company competes with a limited number of asset-light logistics businesses in the organ transportation market.
• Some companies developing organ preservation technology now provide organ transportation services that compete with the company.

Legal Proceedings

• In July 2022, Trinity Air Medical, LLC received a federal grand jury subpoena seeking records related to the provision of transplant transportation services, which was closed on August 2, 2023.
• Two putative class action lawsuits relating to the acquisition of Blade Urban Air Mobility, Inc. were filed in February 2024.

Related Party Transactions

• The company occasionally engages in transactions for certain air charter services with jet operators who are part of the portfolio of RedBird Capital Partners Management LLC.

Stakeholder Impact

• Shareholders may be concerned about the increased net loss and material weaknesses in internal controls.
• Employees may be affected by the company's efforts to manage costs and improve operational efficiency.
• Customers may benefit from the company's expansion into new markets and the potential for lower prices with the adoption of EVA.
• Suppliers and creditors may be impacted by the company's financial performance and ability to meet its obligations.

Next Steps

• The company plans to continue to scale its business using its technology platform.
• The company intends to leverage the expected lower operating costs of EVA to reduce consumer prices.
• The company expects to remediate the identified material weaknesses in internal control over financial reporting during 2024.

Key Dates

Keywords

air mobility, urban air mobility, organ transport, electric vertical aircraft, EVA, eVTOL, helicopter, fixed-wing, medical transportation, passenger transportation, asset-light model, flight operations, financial results